“…Risk factors for mortality in COVID-19 reported in various studies included advanced age [ 2 – 13 ], male gender [ 6 , 7 , 9 , 11 , 13 ] and comorbidities [ 3 , 5 , 6 , 9 – 16 ] like diabetes mellitus, obesity, systemic hypertension, renal diseases, coronary artery disease [ 12 ] and malignancy. Apart from manifestations such as fever [ 8 ], cough [ 8 ], haemoptysis [ 2 ], dyspnoea [ 2 , 6 , 8 ], fatigue [ 8 ], loss of consciousness [ 2 , 6 ], laboratory parameters such as elevation of Neutrophil-to-Lymphocyte Ratio (NLR) [ 2 , 15 ], and increased levels of creatinine [ 3 ], lactate dehydrogenase (LDH) [ 2 – 4 , 10 , 12 ], direct bilirubin [ 2 ] and alanine aminotransferase [ 3 ], which provide early clues to the severity of disease, an increased plasma level of biomarkers like D-dimer [ 3 – 5 , 12 ], C-Reactive Protein (CRP) [ 6 , 7 ], serum ferritin [ 3 ], Interleukin-6 (IL-6) [ 3 ], and procalcitonin (PCT) fortifies these findings[ 3 – 5 ]. With the efficacy of specific antiviral and targeted immunomodulatory therapy still remaining elusive, prediction of mortality and risk stratification offers a rational approach for health resources allocation.…”